Europe – From laboratory to patient: the journey of a centrally authorised medicine

Tens of thousands of substances are investigated every year by pharmaceutical and biotechnology companies, as well as doctors and academics, for their potential to treat diseases. Only a small number will ever be promising enough to be tested in patients and just a fraction of these will ever have study results good enough to reach the market.

The initial research on medicines is usually done by pharmaceutical and biotechnology companies – some big companies develop many medicines, while others are small companies who may only be researching one or two. Doctors and academics also perform research, and may get together to research either new medicines or new uses of old medicines…